R&D Clinical Trials Round-Up: July/August 2026 While the volume of announcements hit a mid-year slump, July and August still produced an exciting array of updates across the drug development arena.
R&D How AI simulation could help de-risk obesity and cardiometab... AI life sciences models allow researchers to explore different patient populations, protocols, and development strategies before a study starts.
Patients The cardio-renal-metabolic space and obesity as a chronic di... The podcast welcomes Dr Ramy Younes, corporate VP, global head of clinical development, cardiorenalmetabolism, at Boehringer Ingelheim.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.